Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Verifiedinfo

Onkopraxis Probstheida

Germany Struempellstrasse 42, Probstheida, 04289 Leipzig, Germany

  • Rectal cancer · Colon cancer stage II · Rectal cancer stage II
  • Adult patients

About Specializations

Onkopraxis Probstheida in Leipzig, Germany specialises in clinical trials of conditions such as Rectal cancer, Colon cancer stage II, Rectal cancer stage II, Chronic lymphocytic leukaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Onkopraxis Probstheida – Cancer Clinical Research

The clinic concentrates on advancing care for solid tumors, particularly colorectal cancer and Hodgkin lymphoma, by testing novel adjuvant therapy approaches and less toxic treatment options.

  • Adjuvant treatment guided by circulating tumor DNA
  • Risk‑adapted chemotherapy for locally advanced rectal cancer
  • Reduced‑toxicity regimens for advanced Hodgkin lymphoma

With three active studies and two investigators, Onkopraxis Probstheida seeks to boost disease‑free survival while minimizing treatment‑related morbidity for patients with stage II colon and rectal cancers and for those battling advanced Hodgkin lymphoma.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Struempellstrasse 42, Probstheida04289 LeipzigGermany
Open in maps ↗
Recruiting now
no trials
Conditions studied
5
Partner status
Verified

More sites in LeipzigGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne

Rectal cancer

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Heidelberg University

Colon cancer stage II+1

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Technische Universitaet Dresden

Chronic lymphocytic leukaemia

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne

Oesophageal adenocarcinoma

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sacituzumab Govitecan
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.